Biodexa Pharmaceuticals Plc carries a market capitalization of 632,704.00, placing it among publicly traded companies globally.
| Market Cap | 632,704.00 |
| Enterprise Value | N/A |
Biodexa Pharmaceuticals Plc's stock has declined approximately -97.02977% over the past 52 weeks. The 50-day moving average sits at 1.76, while the 200-day moving average is 7.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | -97.02977% |
| 50-Day Moving Average | 1.76 |
| 200-Day Moving Average | 7.02 |
| Average Volume (20 Days) | N/A |
Biodexa Pharmaceuticals Plc's most recent stock split took place on April 6, 2026 with a 5:1 split ratio.
| Last Split Date | 4/6/2026 |
| Split Ratio | 5:1 |